ClinicalTrials.govpublic full text
Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study
depression, depression children reboxetine, a diagnosis of major depressive disorder or a dysthimic disorder according to dsm-iv-tr., drug naïve or without chronic medication for at least one month., only children who agree to participate and whose parents will sign and informed consent form will be included., interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 870522
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.